Promoters to issue up to Rs 175 cr NCDs; share pledge rises to 27.96%
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved in line with Nifty Microcap 250 and 0.8 pts more than its Retailing peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Promoters Agilemed Investments and MD and CEO Gangadi Madhukar Reddy executed a Debenture Trust Deed on Dec 12, 2025 to issue up to Rs 175 crore non-convertible debentures at 12.72% interest, to refinance existing promoter debt. Promoter share pledge will temporarily rise from 23.91% to 27.96% during the interim, and is expected to fall to about 24.48% after refinancing completes. The company itself is not a party to the agreement.
Temporary rise in promoter share pledge from 23.91% to 27.96% during debt refinancing; expected to drop to about 24.48% post completion.